Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report
Conclusion
The VILL is a psychometrically sound patient-reported outcome instrument, and the results further support its reliability and validity across all AMD stages. We recommend the shortened version of the questionnaire with three subscales (VILL-33) for future use.
Trial registration number
NCT03349801.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Terheyden, J. H., Pondorfer, S. G., Behning, C., Berger, M., Carlton, J., Rowen, D., Bouchet, C., Poor, S., Luhmann, U. F. O., Leal, S., Holz, F. G., Butt, T., Brazier, J. E., Finger, R. P., the MACUSTAR consortium, Agostini, Altay, Atia, Bandello, Basile Tags: Open access Original articles - Clinical science Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Denmark Health | France Health | Germany Health | Italy Health | Netherlands Health | Opthalmology | Portugal Health | Science | Study | UK Health